Harbin Medisan Pharmaceutical Co.,Ltd.’s Net Profit Rose 2586.6% in First Three Quarters of 2021

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net profit of 539 million yuan in the first three quarters of 2021, up 2586.6% year-on-year.

Meanwhile, the company posted 707.7 million yuan in revenue, down 26.8% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 734.1 million yuan in total liabilities, with a liability-to-asset ratio of 24.2%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.